Hiemke C - Search Results

1

Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis.

Hart XM, Hiemke C, Eichentopf L, Lense XM, Clement HW, Conca A, Faltraco F, Florio V, Grüner J, Havemann-Reinecke U, Molden E, Paulzen M, Schoretsanitis G, Riemer TG, Gründer G. Hart XM, et al. Among authors: hiemke c. Psychopharmacology (Berl). 2022 Nov;239(11):3377-3391. doi: 10.1007/s00213-022-06233-2. Epub 2022 Oct 5. Psychopharmacology (Berl). 2022. PMID: 36195732 Free PMC article. Review.

2

The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.

Gründer G, Wetzel H, Hillert A, Jochum E, Hiemke C, Benkert O. Gründer G, et al. Among authors: hiemke c. Psychopharmacology (Berl). 1995 Feb;117(4):472-8. doi: 10.1007/BF02246221. Psychopharmacology (Berl). 1995. PMID: 7604150

3

Inhibition of dextromethorphan metabolism by moclobemide.

Härtter S, Dingemanse J, Baier D, Ziegler G, Hiemke C. Härtter S, et al. Among authors: hiemke c. Psychopharmacology (Berl). 1998 Jan;135(1):22-6. doi: 10.1007/s002130050481. Psychopharmacology (Berl). 1998. PMID: 9489930

4

Neuroendocrine response to antipsychotics: effects of drug type and gender.

Gründer G, Wetzel H, Schlösser R, Anghelescu I, Hillert A, Lange K, Hiemke C, Benkert O. Gründer G, et al. Among authors: hiemke c. Biol Psychiatry. 1999 Jan 1;45(1):89-97. doi: 10.1016/s0006-3223(98)00125-5. Biol Psychiatry. 1999. PMID: 9894580 Clinical Trial.

5

Increase in serum clomipramine concentrations caused by valproate.

Fehr C, Gründer G, Hiemke C, Dahmen N. Fehr C, et al. Among authors: hiemke c. J Clin Psychopharmacol. 2000 Aug;20(4):493-4. doi: 10.1097/00004714-200008000-00019. J Clin Psychopharmacol. 2000. PMID: 10917416 No abstract available.

6

New dopamine D2 receptor polymorphisms in rats and association with apomorphine-induced stereotypies.

Germeyer S, Birke A, Schmitt U, Dahmen N, Hiemke C, Havemann-Reinecke U. Germeyer S, et al. Among authors: hiemke c. Brain Res. 2002 Feb 1;926(1-2):1-9. doi: 10.1016/s0006-8993(01)03136-5. Brain Res. 2002. PMID: 11814400

7

Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects.

Hiemke C, Peled A, Jabarin M, Hadjez J, Weigmann H, Härtter S, Modai I, Ritsner M, Silver H. Hiemke C, et al. J Clin Psychopharmacol. 2002 Oct;22(5):502-6. doi: 10.1097/00004714-200210000-00010. J Clin Psychopharmacol. 2002. PMID: 12352274 Clinical Trial.

8

Therapeutic monitoring of new antipsychotic drugs.

Hiemke C, Dragicevic A, Gründer G, Hätter S, Sachse J, Vernaleken I, Müller MJ. Hiemke C, et al. Ther Drug Monit. 2004 Apr;26(2):156-60. doi: 10.1097/00007691-200404000-00012. Ther Drug Monit. 2004. PMID: 15228157 Review.

9

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia.

Vernaleken I, Siessmeier T, Buchholz HG, Härtter S, Hiemke C, Stoeter P, Rösch F, Bartenstein P, Gründer G. Vernaleken I, et al. Among authors: hiemke c. Int J Neuropsychopharmacol. 2004 Dec;7(4):421-30. doi: 10.1017/S1461145704004353. Int J Neuropsychopharmacol. 2004. PMID: 15683553 Free article.

10

The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.

Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P. Gründer G, et al. Among authors: hiemke c. Neuropsychopharmacology. 2006 May;31(5):1027-35. doi: 10.1038/sj.npp.1300931. Neuropsychopharmacology. 2006. PMID: 16237387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters